These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6736346)

  • 21. Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application.
    Weber U; Kern W; Novotny GE; Goerz G; Hanappel S
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):198-205. PubMed ID: 3111945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Canthaxanthine retinopathy: 1. Clinical study in 51 consumers].
    Boudreault G; Cortin P; Corriveau LA; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1983 Dec; 18(7):325-8. PubMed ID: 6423246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine.
    Farr PM; Diffey BL; Matthews JN
    Br J Dermatol; 1990 Jun; 122(6):809-15. PubMed ID: 1973359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Canthaxanthin retinopathy and macular pucker--clinical picture and ultrastructural findings of macular pucker].
    Bopp S; el-Hifnawi E; Laqua H
    Fortschr Ophthalmol; 1989; 86(5):456-60. PubMed ID: 2511128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of erythropoietic protoporphyria. Experience with beta-carotene.
    Zaynoun ST; Hunter JA; Darby FJ; Zarembski P; Johnson BE; Frain-Bell W
    Br J Dermatol; 1977 Dec; 97(6):663-8. PubMed ID: 603748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [B-carotene as the therapeutic agent for erythropoetic protoporphyria, not the last resort].
    Kuhlwein A; Beykirch W
    Z Hautkr; 1980 Jun; 55(12):817-23. PubMed ID: 7415363
    [No Abstract]   [Full Text] [Related]  

  • 27. [Carotinoid deposits in the retina].
    Philipp W
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):439-40. PubMed ID: 3936971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Canthaxanthin retinopathy].
    Nijman NM; Oosterhuis JA; van Bijsterveld OP; Baart de la Faille H; Suurmond D
    Klin Monbl Augenheilkd; 1989 Jan; 194(1):48-51. PubMed ID: 2496261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial.
    Corbett MF; Herxheimer A; Magnus IA; Ramsay CA; Kobza-Black A
    Br J Dermatol; 1977 Dec; 97(6):655-62. PubMed ID: 341955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of erythropoietic protoporphyria.
    Poh-Fitzpatrick MB
    Compr Ther; 1984 May; 10(5):12-7. PubMed ID: 6734124
    [No Abstract]   [Full Text] [Related]  

  • 31. Beta-carotene content of certain organs from two patients receiving high doses of beta-carotene.
    Mathews-Roth MM; Abraham AA; Gabuzda TG
    Clin Chem; 1976 Jun; 22(6):922-4. PubMed ID: 1277485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Canthaxanthin retinopathy and macular pucker].
    Bopp S; el-Hifnawi EL; Laqua H
    J Fr Ophtalmol; 1989; 12(12):891-6. PubMed ID: 2517961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystalline retinopathy in patients taking an oral drug containing canthaxanthine.
    Ros AM; Leyon H; Wennersten G
    Photodermatol; 1985 Jun; 2(3):183-5. PubMed ID: 3927272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Canthaxanthin retinopathy. Follow-up of over 6 years].
    Weber U; Goerz G; Baseler H; Michaelis L
    Klin Monbl Augenheilkd; 1992 Sep; 201(3):174-7. PubMed ID: 1405396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new case of retinal thesaurismosis due to canthaxanthin].
    Segal A; Laporte P; Ducasse A; Vidal S
    Bull Soc Ophtalmol Fr; 1985 Jan; 85(1):145-7. PubMed ID: 3935341
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of photodermatoses with carotinoids (author's transl)].
    Goerz G; Ippen H
    Dtsch Med Wochenschr; 1977 Jul; 102(29):1051-5. PubMed ID: 891378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of canthaxanthin on the photocutaneous manifestations of porphyria.
    Eales L
    S Afr Med J; 1978 Dec; 54(25):1050-2. PubMed ID: 371027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canthaxanthin retinopathy.
    Lonn LI
    Arch Ophthalmol; 1987 Nov; 105(11):1590-1. PubMed ID: 3118860
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
    Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LH; Kass EH
    Arch Dermatol; 1977 Sep; 113(9):1229-32. PubMed ID: 900968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrohepatic protoporphyria and its treatment with beta-carotene.
    Krook G; Haeger-Aronsen B
    Acta Derm Venereol; 1974; 54(1):39-44. PubMed ID: 4135165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.